<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The monoclonal antibody termed SN10 (IgG1-k) which was generated and characterized in the present study shows a highly selective reactivity with fresh (uncultured) human <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="1" pm="."><plain>The antigen defined by SN10 is a cell surface <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> composed of a single <z:chebi fb="0" ids="16541">polypeptide chain</z:chebi> of Mr 36,000 and designated as gp36 </plain></SENT>
<SENT sid="2" pm="."><plain>The primary reactivity of SN10 is against mature B-lineage <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="3" pm="."><plain>For instance, SN10 reacted with <z:hpo ids='HP_0000001'>all</z:hpo> of the 17 B non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> specimens, <z:hpo ids='HP_0000001'>all</z:hpo> of the 15 B <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> specimens, both of the 2 B prolymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> specimens, <z:hpo ids='HP_0000001'>all</z:hpo> of the 3 B hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> specimens, and 2 of the 3 B <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> specimens tested </plain></SENT>
<SENT sid="4" pm="."><plain>Of <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood cells, only a marginal reactivity of SN10 was detected with a minor subpopulation (less than 1-4% among different specimens) of isolated B-cells from healthy donors </plain></SENT>
<SENT sid="5" pm="."><plain>No significant reactivity of SN10 was detected against any other isolated <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood cells which include T-cells, granulocytes, monocytes, erythrocytes, and platelets </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, no significant reactivity of SN10 was detected against <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow specimens </plain></SENT>
<SENT sid="7" pm="."><plain>In immunohistological studies using frozen tissue sections, SN10 reacted well with malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and showed varying patterns of reaction with hyperplastic reactive lymph nodes </plain></SENT>
<SENT sid="8" pm="."><plain>Various <z:mpath ids='MPATH_458'>normal</z:mpath> human tissues tested were unreactive with SN10 </plain></SENT>
<SENT sid="9" pm="."><plain>In general, <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 36 was more abundantly expressed on fresh (uncultured) <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells than on cultured <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines </plain></SENT>
<SENT sid="10" pm="."><plain>No significant amount of circulating SN10 antigen was detected in the plasma of <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients or <z:mpath ids='MPATH_458'>normal</z:mpath> healthy donors </plain></SENT>
<SENT sid="11" pm="."><plain>Scatchard plot analysis of direct binding of radiolabeled SN10 to a fresh (uncultured) B non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell specimen, a fresh B <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> cell specimen, and DND-39 (an American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line) showed equilibrium constants of 5.2, 5.8, and 6.8 x 10(8) liters/mol, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, SN10 shows a high binding avidity to each of the 3 B <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell specimens tested </plain></SENT>
<SENT sid="13" pm="."><plain>Ricin A chain conjugate of SN10 killed <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells effectively, whereas the same conjugate showed no cytotoxicity against control cells </plain></SENT>
<SENT sid="14" pm="."><plain>Thus, SN10 bound to target antigen on the cell surface was effectively internalized into the cell </plain></SENT>
<SENT sid="15" pm="."><plain>The present results suggest the potential of SN10 for therapy as well as for diagnosis of various forms of <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo>, particularly mature B-lineage <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>